Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, October 28 at 2:00 PM ET

Register Free →

This Government Contract opportunity was posted on July 7, 2015. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

InVitro Metabolism and Metabolite Quantification

Awarded
N01DA-15-8919Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

AI Contract Overview

Show more

The National Institute on Drug Abuse is seeking proposals for an Indefinite Delivery Indefinite Quantity contract to provide in vitro metabolism and permeability determinations for its medications development program. The scope of work includes metabolite profiling using hepatocytes and microsomes, CYP 450 phenotyping, inhibition, and induction, as well as potential evaluations of hepatic cytosol and Phase II reactions. Additionally, the selected contractor will be responsible for the structure identification of major metabolites via mass spectrometry or NMR and determining the permeabilities of new compounds regarding the blood-brain barrier and intestines. To be eligible, offerors must hold a DEA Registration for Chemical Analysis or Research Registration for Schedules II to V and show the ability to obtain registration for Schedule I controlled substances. The government intends to issue fixed price task orders under this agreement. Interested parties must follow the guidelines set forth in RFP No. N01DA-15-8919, with proposals due 45 days after the solicitation's issuance.

General Info

Agency

N/A

Contract Value

$403,276.3

NAICS

541712 - Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)

Place of Performance

KS, USA

Set-Aside

NONE

Award Issued Date

Documents

0

No documents available

Documents will appear here when they are available.

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Timeline

PhaseAwarded
Posted

Presolicitation

Type Changed

Presolicitation → Solicitation

Awarded

Contract was awarded

Submission Closed

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyN/A
Contacts2 people available
OfficeN/A
Organization / Agency
N/A
Office AddressN/A
Contacts
Lisa V. BielenContract Specialist
Brian H O'LaughlinContracting Officer

Full Description

Show more
The National Institute on Drug Abuse (NIDA) intends to solicit proposals from qualified businesses to provide in vitro metabolism and permeability determinations for its medications development program in support of the Division of Pharmacotherapies and Medical Consequences of Drug Abuse (DPMCDA). The in vitro metabolism studies for this contract typically include metabolite profiling for interspecies comparison using hepatocytes and microsomes, CYP 450 phenotyping reaction, CYP 450 inhibition, and CYP 450 induction for potential medications. It may also include evaluation of in vitro metabolism by other systems such as hepatic cytosol, hepatic mitochondrial fraction, or Phase II reactions (glucuronidation, sulfation, acetylation, methylation, conjugation with glutathione, conjugation with amino acids). This contract may also provide structure identification of major metabolites by mass spectrometry or nuclear magnetic resonance (NMR). Additional in vitro studies include determination of intestinal and blood-brain barrier permeabilities of new compounds. In order to handle substances under the Controlled Substances Act of 1970, it is mandatory that offerors possess a DEA Registration for Chemical Analysis or Research Registration for Schedules II to V and demonstrate the capability to obtain a DEA registration for Schedule I controlled substances. NIDA anticipates one (1) Indefinite Delivery Indefinite Quantity (Task Order) type contract will be awarded. NIDA plans to issue fixed price task orders. RFP No. N01DA-15-8919 will be available electronically on or about May 19, 2014. You can access the RFP through the FedBizOpps (URL: http://www.fedbizopps.gov or through the NIDA website at the following address: (URL: http://www.nida.nih.gov/RFP/RFPList.html). All information required for the submission of an offer will be contained in or accessible through the RFP package. Response to the RFP will be due 45 days after the solicitation is issued. NIDA will consider proposals submitted by any responsible offeror. Based upon market research, the Government is not using the policies contained in Part 12, Acquisition of Commercial Items, in its solicitation for the described supplies or services. However, interested persons may identify to the Contracting Officer their interest and capability to satisfy the Government's requirement with a commercial item within 15 days of this notice. Disclaimer and Important Notes: This notice is for informational purposes and does not obligate the Government to award a contract or otherwise pay for the information provided in response.

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS